TD Cowen initiated coverage on Exscientia plc
$EXAI
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
TD Cowen initiated coverage of Exscientia plc with a rating of Buy
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/9/2024 | Buy | TD Cowen | |
| 1/5/2024 | $11.00 → $9.00 | Buy → Neutral | BofA Securities |